Psyvox-ER 500 contains Divalproex Sodium in an extended release formulation, specifically designed to effectively manage seizure disorders, bipolar disorder, and migraine prevention. This medication works by stabilizing electrical activity in the brain and balancing neurotransmitters, helping to reduce the frequency and severity of seizures and mood swings. The extended release feature ensures a sustained therapeutic effect, enhancing patient adherence and improving overall treatment outcomes.
Reviews
There are no reviews yet.